Major, James C <br/><br/>
Aflibercept for pigment epithelial detachment for previously treated neovascular age-related macular degeneration.  [electronic resource] 

 -  Canadian journal of ophthalmology. Journal canadien d'ophtalmologie  Oct 2015 
 - 373-7 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1715-3360 
<br/><br/><label>Standard No.: </label>10.1016/j.jcjo.2014.12.012  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Angiogenesis Inhibitors--therapeutic use<br/>Bevacizumab--therapeutic use<br/>Drug Substitution<br/>Female<br/>Humans<br/>Intravitreal Injections<br/>Male<br/>Middle Aged<br/>Ranibizumab--therapeutic use<br/>Receptors, Vascular Endothelial Growth Factor--therapeutic use<br/>Recombinant Fusion Proteins--therapeutic use<br/>Retinal Detachment--diagnosis<br/>Retinal Pigment Epithelium--drug effects<br/>Retrospective Studies<br/>Tomography, Optical Coherence<br/>Vascular Endothelial Growth Factor A--antagonists & inhibitors<br/>Visual Acuity--drug effects<br/>Wet Macular Degeneration--drug therapy